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A corrigendum on
The role of drug transporters in the kid-
ney lessons from tenofovir
by Moss, D. M., Neary, M., and Owen,
A. (2014). Front. Pharmacol. 5:248. doi:
10.3389/fphar.2014.00248
The authors wish to correct a mis-
take on the review “The role of drug
transporters in the kidney: lessons from
tenofovir” regarding the details of a par-
ticular ABCC2 polymorphism [−24C >
T (rs717620)]. In the Section “Tenofovir
and kidney transporter pharmacogenet-
ics” on page five of the article, the second
line on the second column should state
the ABCC2 polymorphism as −24C > T,
rather than −24T > C. Additionally, the
sentence beginning on page five, line four
of the second column should be changed
from: “In a study in Japanese HIV+
patients, the ABCC2−24C> T and1249G
> A polymorphisms were found to be
protective for tenofovir-induced kidney
toxicity (Nishijima et al., 2012).” and
instead read: “In a study in Japanese
HIV+ patients, the ABCC2−24T> C and
1249G > A polymorphisms were found
to be associated with the increased occur-
rence of tenofovir-induced kidney toxicity
(Nishijima et al., 2012).”
REFERENCES
Nishijima, T., Komatsu, H., Higasa, K., Takano, M.,
Tsuchiya, K., Hayashida, T., et al. (2012). Single
nucleotide polymorphisms in ABCC2 associate
with tenofovirinduced kidney tubular dysfunc-
tion in Japanese patients with HIV-1 infection:
a pharmacogenetic study. Clin. Infect. Dis. 55,
1558–1567. doi: 10.1093/cid/ cis772
Conflict of Interest Statement: The author declares
that the research was conducted in the absence
of any commercial or financial relationships
that could be construed as a potential conflict of
interest.
Received: 22 December 2014; accepted: 20 January 2015;
published online: 09 February 2015.
Citation: Moss DM (2015) Corrigendum: The role of
drug transporters in the kidney: lessons from tenofovir.
Front. Pharmacol. 6:18. doi: 10.3389/fphar.2015.00018
This article was submitted to Experimental
Pharmacology and Drug Discovery, a section of
the journal Frontiers in Pharmacology.
Copyright © 2015 Moss. This is an open-access
article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, dis-
tribution or reproduction in other forums is permit-
ted, provided the original author(s) or licensor are
credited and that the original publication in this
journal is cited, in accordance with accepted aca-
demic practice. No use, distribution or reproduc-
tion is permitted which does not comply with these
terms.
www.frontiersin.org February 2015 | Volume 6 | Article 18 | 1
